Acute Injury and Exudative Phase
The triggering mechanism of the syndrome involves biologically active substances that cause massive activation of alveolar macrophages, neutrophils, and other granulocytes. These cells adhere to the microvascular endothelium and release lysosomal enzymes, cytotoxic agents, and reactive oxygen species, triggering lipid peroxidation.
Primary targets for injury include:
- Capillary endothelium
- Alveolar epithelium (including type I alveolar cells)
- Basement membrane of the blood-air barrier
- Surfactant (leading to its depletion)
Such destruction leads to a sharp increase in barrier permeability to proteins, including fibrin, and blood cellular elements. As a result, interstitial and alveolar edema rapidly accumulates, gas exchange is impaired, and respiratory hypoxia develops.
Pathophysiology and Vascular Alterations
A crucial role in the development of the pathology is played by damage to type II alveolar cells, which are responsible for surfactant production. Their destruction leads to alveolar collapse, atelectasis formation, a rapid drop in lung compliance, and an increase in intrapulmonary shunting.
Pronounced vascular disorders develop in the pulmonary microcirculation, leading to pulmonary hypertension. The causes are vascular occlusion by multiple thrombi and marked vasoconstriction. Spastic reactions are sustained by mediators such as:
- Hypoxia
- Thromboxane $A_2$
- Leukotrienes
- Kinins and endothelin
Morphologically, this period is characterized by infiltration of the lung tissue with macrophages and lymphocytes, as well as proliferation of cells and the extracellular matrix.
Fibrotic Stage and Systemic Manifestations
In areas of the most intense injury, the fibrotic stage develops. Excessive influx of proteins and erythrocytes into the alveoli, combined with leukocyte migration, stimulates the synthesis of collagen, argyrophilic, and elastic fibers as well as extracellular matrix components, leading to localized pulmonary fibrosis.
Systemic changes encompass multiple organs and functions:
- Respiratory system: tachypnea, increased minute ventilation, and decreased lung volumes (TLC, RV, VC, FRC).
- Acid-base balance: early respiratory alkalosis is replaced by hypercapnia and acidosis.
- Hemodynamics: a compensatory increase in cardiac output initially is followed by its decline in the terminal phase.
- Multiorgan dysfunction: signs of acute multiple organ dysfunction syndrome (MODS) emerge, determining a poor prognosis.